AbbVie Operating Income 2012-2026 | ABBV

AbbVie operating income for the twelve months ending March 31, 2026 was $15.332B, a 52.22% increase year-over-year.

  • AbbVie annual operating income for 2025 was $15.075B, a 64.99% increase from 2024.
  • AbbVie annual operating income for 2024 was $9.137B, a 28.38% decline from 2023.
  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.

AbbVie Operating Income 2012-2026 | ABBV

  • AbbVie annual operating income for 2025 was $15.075B, a 64.99% increase from 2024.
  • AbbVie annual operating income for 2024 was $9.137B, a 28.38% decline from 2023.
  • AbbVie annual operating income for 2023 was $12.757B, a 29.59% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B